14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.282 $0.459 Wednesday, 28th Feb 2024 WINT stock ended at $0.356. This is 0.475% less than the trading day before Tuesday, 27th Feb 2024. During the day the stock fluctuated 7.29% from a day low at $0.350 to a day high of $0.376.
90 days $0.282 $1.24
52 weeks $0.282 $18.48

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
2024-02-28 $0.376 $0.376 $0.350 $0.356 95 576
2024-02-27 $0.310 $0.366 $0.310 $0.358 129 482
2024-02-26 $0.320 $0.328 $0.305 $0.328 41 025
2024-02-23 $0.320 $0.320 $0.301 $0.318 63 911
2024-02-22 $0.330 $0.338 $0.282 $0.317 273 886
2024-02-21 $0.333 $0.335 $0.320 $0.335 91 956
2024-02-20 $0.365 $0.365 $0.324 $0.325 220 135
2024-02-16 $0.353 $0.363 $0.350 $0.355 61 378
2024-02-15 $0.361 $0.369 $0.356 $0.357 159 712
2024-02-14 $0.370 $0.375 $0.350 $0.368 86 900
2024-02-13 $0.379 $0.379 $0.354 $0.364 85 715
2024-02-12 $0.360 $0.399 $0.354 $0.378 189 613
2024-02-09 $0.370 $0.380 $0.348 $0.360 198 001
2024-02-08 $0.350 $0.399 $0.349 $0.363 219 761
2024-02-07 $0.380 $0.380 $0.340 $0.360 182 632
2024-02-06 $0.371 $0.380 $0.355 $0.360 258 750
2024-02-05 $0.388 $0.395 $0.365 $0.369 217 909
2024-02-02 $0.410 $0.415 $0.384 $0.400 325 836
2024-02-01 $0.438 $0.438 $0.370 $0.410 201 998
2024-01-31 $0.450 $0.450 $0.417 $0.420 433 130
2024-01-30 $0.450 $0.452 $0.430 $0.450 251 865
2024-01-29 $0.417 $0.459 $0.415 $0.458 205 363
2024-01-26 $0.450 $0.480 $0.427 $0.430 521 348
2024-01-25 $0.490 $0.522 $0.436 $0.447 1 038 433
2024-01-24 $0.450 $0.460 $0.433 $0.460 108 346
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT